Poly Medicure Fund Raise of ₹1,000 Cr

Poly Medicure Earnings Call Transcript: Key Takeaways

Consolidated Q2 revenue rose 31%, but H1 organic growth was only 14%. Pendra Care is loss-making and Italy tenders are delayed. FY27 revenue guidance was reaffirmed and the standalone margin band raised.

Call

Guides 100% growth

Poly Medicure Other Announcement

Poly Medicure's board revised five governance policies and codes, including material subsidiary, materiality, related party transactions, and insider trading codes. The revised documents are published on the company website.

Poly Medicure Q2 FY27 Results: Net Profit ₹95.1 Cr, Up 3.6% YoY

Poly Medicure Ltd reported revenue from operations of ₹580.5 Cr (+30.8% YoY) and net profit of ₹95.1 Cr (+3.6% YoY) for Q2 FY27.

Key figure

Net profit ₹95.1 Cr · +3.6% YoY

Poly Medicure Board Meeting Date

Poly Medicure will hold a board meeting on 05 November 2026 to consider unaudited results. Trading window stays closed until 07 November 2026.

Poly Medicure Other Announcement

The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).

Poly Medicure Annual General Meeting

Poly Medicure conducted its 31st Annual General Meeting on September 5, 2026, via video conferencing. This filing provides a summary of the meeting's proceedings and agenda items.

Om Metallogic Fund Raise

Om Metallogic Ltd intimated a board meeting on 14 November 2026 to approve rights issue issue price, entitlement ratio, record date and issue dates. The rights issue follows BSE in-principle approval.

Virinchi Fund Raise of ₹30 Cr

Virinchi's board approved a Rs 30 Crore preferential issue of 2 crore convertible warrants at Rs 15 each. Subject to EGM approval, allottees include promoter Viswanath Kompella.

Value

₹30.00 Cr

Execution

Warrant tenure not exceeding 18 months from allotment

IIFL Finance Fund Raise of ₹6,414 Cr

IIFL Finance's board approved a preferential issue of convertible preference shares and warrants worth Rs.6,414.20 Crore. Shareholder approval is needed at a 4 December EGM.

Value

₹6,414 Cr

Bajaj Finance Fund Raise of ₹5,800 Cr

Bajaj Finance's special committee approved issuing 5.74 crore warrants to promoter Bajaj Finserv at ₹1,010 each. The issue raises about ₹5,800 crore.

Value

₹5,800 Cr

Cholamandalam Investment & Finance Company Fund Raise of ₹5,000 Cr

Cholamandalam Investment sent shareholders a postal ballot notice seeking approval for a Rs 5,000 crore QIP. E-voting runs November 10 to December 9, 2026.

Value

₹5,000 Cr

Execution

Allotment to be completed within 365 days of shareholder approval

HB Leasing & Finance Co Fund Raise

HB Leasing's board discussed fund-raising options on November 9, 2026, including equity and preference shares. No quantum or pricing is decided; advisers will be consulted.